From what 11 stock analysts predict, the share price for Aspen Aerogels Inc (ASPN) might increase by 102.7% in the next year. This is based on a 12-month average estimation for ASPN. Price targets go from $25 to $35. The majority of stock analysts believe ASPN is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 11 Wall Street analysts have assigned ASPN 11 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Aspen Aerogels Inc to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ASPN. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ASPN.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
David Anderson Barclays | Overweight | $25 | Maintains | Nov 12, 2024 |
Chip Moore Roth MKM | Buy | $31 | Maintains | Nov 8, 2024 |
Alexander Potter Piper Sandler | Overweight | $33 | Maintains | Oct 22, 2024 |
Amit Dayal HC Wainwright & Co. | Buy | $30 | Reiterates | Oct 16, 2024 |
Chip Moore Roth MKM | Buy | $36 | Reiterates | Aug 21, 2024 |
Jeffrey Osborne TD Cowen | Buy | $41 | Maintains | Aug 20, 2024 |
Amit Dayal HC Wainwright & Co. | Buy | $30 | Maintains | Aug 9, 2024 |
Subash Chandra Benchmark | Buy | $14 | Reiterates | Aug 8, 2024 |
Barclays | Overweight | $27 | Initiates | Aug 6, 2024 |
Eric Stine Craig-Hallum | Buy | $38 | Maintains | Jun 14, 2024 |
Tom Curran Seaport Global | Buy | $38 | Maintains | Jun 13, 2024 |
Chip Moore Roth MKM | Buy | $36 | Reiterates | Jun 12, 2024 |
Jeffrey Osborne TD Cowen | Buy | $36 | Maintains | Jun 5, 2024 |
Alexander Potter Piper Sandler | Overweight | $36 | Maintains | May 29, 2024 |
Alexander Potter Piper Sandler | Overweight | $30 | Maintains | May 14, 2024 |
George Gianarikas Canaccord Genuity | Buy | $28 | Maintains | May 3, 2024 |
Amit Dayal HC Wainwright & Co. | Buy | $25 | Maintains | May 3, 2024 |
Alexander Potter Piper Sandler | Overweight | $29 | Maintains | May 3, 2024 |
Christopher Souther B. Riley Securities | Buy | $30 | Maintains | May 3, 2024 |
Chip Moore Roth MKM | Buy | $28 | Reiterates | May 3, 2024 |
When did it IPO
2014
Staff Count
548
Country
United States
Sector/Industry
Industrials/Building Products & Equipment
CEO
Mr. Donald R. Young
Market Cap
$1.21B
In 2023, ASPN generated $238.7M in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ASPN's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - The materials sector has identified oversold stocks, indicating potential investment opportunities in undervalued companies.
Why It Matters - Oversold stocks in the materials sector indicate potential for price recovery, offering investors a chance to capitalize on undervalued assets for future gains.
Summary - Aspen Aerogels, now a significant EV player, reported Q3 sales up 93% YoY but shares fell nearly 50% due to equity issues and EV demand concerns, despite DOE funding and growth.
Why It Matters - Aspen Aerogels' shift to the EV sector indicates growth potential, but the share drop reflects investor concerns over dilution, EV demand, and capacity challenges, impacting future valuations.
Summary - Aspen Aerogels, Inc. (NYSE: ASPN) will participate in several investor conferences in Q4 2024, including events hosted by Craig-Hallum, Bernstein, Barclays, and Janney.
Why It Matters - Aspen's participation in major investor conferences highlights its commitment to transparency and growth, potentially attracting interest and investment in its sustainability and electrification solutions.
Summary - Aspen Aerogels, Inc. (NYSE: ASPN) will hold its Q3 2024 earnings conference call on November 7, 2024, at 8:30 AM ET. Key participants include CEO Donald R. Young.
Why It Matters - The earnings call will provide insights into Aspen Aerogels' performance, strategic direction, and financial health, influencing investor sentiment and stock valuation.
Summary - Aspen Aerogels reported Q3 2024 revenue of $117.3 million, with a gross margin of 42% and adjusted EBITDA margin of 22%. They raised 2024 outlook to $450 million revenue and $90 million adjusted EBITDA.
Why It Matters - Aspen Aerogels' strong revenue growth, high gross margins, and improved financial outlook signal robust performance, making it an attractive option for investors seeking growth in sustainability sectors.
Summary - Aspen Aerogels (ASPN) reported Q3 earnings of $0.11 per share, surpassing estimates of a $0.10 loss, and improving from a loss of $0.19 per share a year prior.
Why It Matters - Aspen Aerogels' earnings beat expectations and show improvement year-over-year, indicating potential growth and financial stability, which could attract investor interest.